Cargando…
Development and In Vitro–In Vivo Correlation Evaluation of IMM-H014 Extended-Release Tablets for the Treatment of Fatty Liver Disease
This study aimed to develop extended-release tablets containing 25 mg IMM-H014, an original drug formulated by a direct powder pressing method based on pharmaceutical-grade hydrophilic matrix polymers such as hydroxypropyl methylcellulose, to establish an in vitro–in vivo correlation (IVIVC) to pred...
Autores principales: | Zhang, Chi, Shao, Huihui, Han, Zunsheng, Liu, Bo, Feng, Jing, Zhang, Jie, Zhang, Wenxuan, Zhang, Kun, Yang, Qingyun, Wu, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418331/ https://www.ncbi.nlm.nih.gov/pubmed/37569704 http://dx.doi.org/10.3390/ijms241512328 |
Ejemplares similares
-
Development of In Vitro–In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation
por: Mohamed, Mohamed-Eslam F., et al.
Publicado: (2019) -
Biorelevant In Vitro Release Testing and In Vivo Study of Extended-Release Niacin Hydrophilic Matrix Tablets
por: Milanowski, Bartłomiej, et al.
Publicado: (2020) -
Determination of Methyl Methanesulfonate and Ethyl Methylsulfonate in New Drug for the Treatment of Fatty Liver Using Derivatization Followed by High-Performance Liquid Chromatography with Ultraviolet Detection
por: Wang, Yue, et al.
Publicado: (2022) -
In Vitro-In Vivo Correlation Evaluation of Generic Alfuzosin Modified Release Tablets
por: Sanki, Utpal Kumar, et al.
Publicado: (2012) -
Tratado de entomología Imms
por: Richards, O. W.
Publicado: (1983)